LOSARTAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Losartan, and what generic alternatives are available?
Losartan is a drug marketed by Aiping Pharm Inc, Alembic Pharms Ltd, Apotex, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, Zydus Pharms Usa Inc, Sandoz, and Teva Pharms. and is included in forty-one NDAs.
The generic ingredient in LOSARTAN is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOSARTAN?
- What are the global sales for LOSARTAN?
- What is Average Wholesale Price for LOSARTAN?
Summary for LOSARTAN
US Patents: | 0 |
Applicants: | 26 |
NDAs: | 41 |
Drug Prices: | Drug price information for LOSARTAN |
Drug Sales Revenues: | Drug sales revenues for LOSARTAN |
DailyMed Link: | LOSARTAN at DailyMed |